Psoriatic Arthritis Study of Izokibep

Clinical trial NCT05623345 · TERMINATED

Trial details

NCT number: NCT05623345
Sponsor: ACELYRIN Inc.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2022-11-21
Primary completion: 2023-11-30
Enrollment: 351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.